Department of Neurosurgery, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Department of Neurosurgery, University of Ulm, Lindenallee 2, 89312, Günzburg, Germany.
Neurosurg Rev. 2024 Jan 29;47(1):72. doi: 10.1007/s10143-024-02309-z.
Cranioplasty (CP) after decompressive hemicraniectomy (DHC) is a common neurosurgical procedure with a high complication rate. The best material for the repair of large cranial defects is unclear. The aim of this study was to evaluate different implant materials regarding surgery related complications after CP. Type of materials include the autologous bone flap (ABF), polymethylmethacrylate (PMMA), calcium phosphate reinforced with titanium mesh (CaP-Ti), polyetheretherketone (PEEK) and hydroxyapatite (HA). A retrospective, descriptive, observational bicenter study was performed, medical data of all patients who underwent CP after DHC between January 1st, 2016 and December 31st, 2022 were analyzed. Follow-up was until December 31st, 2023. 139 consecutive patients with a median age of 54 years who received either PMMA (56/139; 40.3%), PEEK (35/139; 25.2%), CaP-Ti (21/139; 15.1%), ABF (25/139; 18.0%) or HA (2/139; 1.4%) cranial implant after DHC were included in the study. Median time from DHC to CP was 117 days and median follow-up period was 43 months. Surgical site infection was the most frequent surgery-related complication (13.7%; 19/139). PEEK implants were mostly affected (28.6%; 10/35), followed by ABF (20%; 5/25), CaP-Ti implants (9.5%; 2/21) and PMMA implants (1.7%, 1/56). Explantation was necessary for 9 PEEK implants (25.7%; 9/35), 6 ABFs (24.0%; 6/25), 3 CaP-Ti implants (14.3%; 3/21) and 4 PMMA implants (7.1%; 4/56). Besides infection, a postoperative hematoma was the most common cause. Median surgical time was 106 min, neither longer surgical time nor use of anticoagulation were significantly related to higher infection rates (p = 0.547; p = 0.152 respectively). Ventriculoperitoneal shunt implantation prior to CP was noted in 33.8% (47/139) and not significantly associated with surgical related complications. Perioperative lumbar drainage, due to bulging brain, inserted in 38 patients (27.3%; 38/139) before surgery was protective when it comes to explantation of the implant (p = 0.035). Based on our results, CP is still related to a relatively high number of infections and further complications. Implant material seems to have a high effect on postoperative infections, since surgical time, anticoagulation therapy and hydrocephalus did not show a statistically significant effect on postoperative complications in this study. PEEK implants and ABFs seem to possess higher risk of postoperative infection. More biocompatible implants such as CaP-Ti might be beneficial. Further, prospective studies are necessary to answer this question.
去骨瓣减压术后颅骨修补术(CP)是一种常见的神经外科手术,其并发症发生率较高。目前哪种材料最适合修复大的颅骨缺损尚不清楚。本研究旨在评估不同植入物材料在 CP 术后相关手术并发症方面的差异。材料类型包括自体骨瓣(ABF)、聚甲基丙烯酸甲酯(PMMA)、钛网增强磷酸钙(CaP-Ti)、聚醚醚酮(PEEK)和羟基磷灰石(HA)。本研究为回顾性、描述性、观察性的双中心研究,分析了 2016 年 1 月 1 日至 2022 年 12 月 31 日期间行 DHC 后接受 CP 的所有患者的医疗数据。随访至 2023 年 12 月 31 日。共纳入 139 例连续患者,中位年龄 54 岁,其中 56/139(40.3%)例患者接受 PMMA、35/139(25.2%)例患者接受 PEEK、21/139(15.1%)例患者接受 CaP-Ti、25/139(18.0%)例患者接受 ABF、2/139(1.4%)例患者接受 HA 颅骨植入物。从 DHC 到 CP 的中位时间为 117 天,中位随访时间为 43 个月。手术部位感染是最常见的手术相关并发症(13.7%;19/139)。PEEK 植入物受影响最大(28.6%;10/35),其次是 ABF(20%;5/25)、CaP-Ti 植入物(9.5%;2/21)和 PMMA 植入物(1.7%;1/56)。9 个 PEEK 植入物(25.7%;9/35)、6 个 ABF(24.0%;6/25)、3 个 CaP-Ti 植入物(14.3%;3/21)和 4 个 PMMA 植入物(7.1%;4/56)需要取出。除感染外,术后血肿是最常见的原因。中位手术时间为 106 分钟,较长的手术时间和抗凝治疗均与较高的感染率无关(p=0.547;p=0.152)。33.8%(47/139)患者在 CP 前接受了脑室-腹腔分流术,与手术相关并发症无显著相关性。由于脑膨出,38 例患者(27.3%;38/139)在术前进行了腰大池引流,在植入物取出方面具有保护作用(p=0.035)。基于我们的结果,CP 仍然与相对较高数量的感染和其他并发症相关。植入物材料似乎对术后感染有很大的影响,因为在本研究中,手术时间、抗凝治疗和脑积水对术后并发症没有统计学意义。PEEK 植入物和 ABF 似乎有更高的术后感染风险。更具生物相容性的植入物,如 CaP-Ti,可能有益。需要进一步的前瞻性研究来回答这个问题。
Acta Chir Orthop Traumatol Cech. 2019
Acta Neurochir (Wien). 2024-9-25
Biomolecules. 2023-3-2
Front Neurol. 2023-1-12
World Neurosurg. 2022-8